| Projected Clinical, Resource Use, and Fiscal Impacts of Implementing Low-Dose Computed Tomography Lung Cancer Screening in Medicare. |
25943596
|
Roth JA, Sullivan SD, Goulart BH, Ravelo A, Sanderson JC, Ramsey SD |
J Oncol Pract |
2015 |
NLST |
| Cost-effectiveness of Lung Cancer Screening in Canada. |
26226181
|
Goffin JR, Flanagan WM, Miller AB, Fitzgerald NR, Memon S, Wolfson MC, Evans WK |
JAMA Oncol |
2015 |
NLST |
| Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. |
26199983
|
Young RP, Duan F, Chiles C, Hopkins RJ, Gamble GD, Greco EM, Gatsonis C, Aberle D |
Am. J. Respir. Crit. Care Med. |
2015 |
NLST |
| Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals. |
25837734
|
Fitzgerald NR, Flanagan WM, Evans WK, Miller AB, Canadian Partnership against Cancer (CPAC) Cancer Risk Management (CRM) Lung Cancer Working |
Scand J Work Environ Health |
2015 |
NLST |
| Comorbidities, smoking status, and life expectancy among individuals eligible for lung cancer screening. |
26372542
|
Howard DH, Richards TB, Bach PB, Kegler MC, Berg CJ |
Cancer |
2015 |
NLST |
| Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign. |
26356134
|
Balekian AA, Fisher JM, Gould MK |
Chest |
2015 |
NLST |
| The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. |
26502000
|
Tanner NT, Kanodra NM, Gebregziabher M, Payne E, Halbert CH, Warren GW, Egede LE, Silvestri GA |
Am. J. Respir. Crit. Care Med. |
2015 |
NLST |
| Racial Differences in Tobacco Cessation and Treatment Usage After Lung Screening: An Examination of the National Lung Screening Trial. |
26712960
|
Kumar P, Gareen IF, Lathan C, Sicks JD, Perez GK, Hyland KA, Park ER |
Oncologist |
2015 |
NLST |
| Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial. |
26602092
|
Lotan Y, Karam JA, Shariat SF, Gupta A, Roupret M, Bensalah K, Margulis V |
Urol. Oncol. |
2015 |
NLST, PLCO |
| The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results. |
26238115
|
Gohagan JK, Prorok PC, Greenwald P, Kramer BS |
Rev Recent Clin Trials |
2015 |
NLST, PLCO |
| Bayesian Estimation of the Three Key Parameters in CT for the National Lung Screening Trial Data |
|
Ruiqi Liu, Beth Levitt, Tom Riley, Dongfeng Wu |
J Biom Biostat |
2015 |
NLST |
| Computer-Assisted Diagnosis of Lung Cancer Using Quantitative Topology Features |
|
Jiawen Yao
, Dheeraj Ganti
, Xin Luo
, Guanghua Xiao
, Yang Xie
, Shirley Yan
, Junzhou Huang |
MLMI 2015 |
2015 |
NLST |
| Culturally sensitive approaches to recruitment and retention of Hispanics in the national lung screening trial. |
23780349
|
Tenorio SL, O'Donnell CI, Hernandez J, Rozjabek HM, Lynch D, Marcus PM |
J Immigr Minor Health |
2014 |
NLST |
| Overdiagnosis in low-dose computed tomography screening for lung cancer. |
24322569
|
Patz EF, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, Chiles C, Black WC, Aberle DR, NLST Overdiagnosis Manuscript Writing Team |
JAMA Intern Med |
2014 |
NLST |
| National Lung Screening Trial findings by age: Medicare-eligible versus under-65 population. |
25199624
|
Pinsky PF, Gierada DS, Hocking W, Patz EF, Kramer BS |
Ann. Intern. Med. |
2014 |
NLST |
| Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials. |
25192282
|
O'Grady TJ, Kitahara CM, DiRienzo AG, Boscoe FP, Gates MA |
PLoS ONE |
2014 |
NLST, PLCO |
| The impact of the regimen of screening on lung cancer cure: a comparison of I-ELCAP and NLST. |
25089376
|
Yip R, Henschke CI, Yankelevitz DF, Boffetta P, Smith JP, International Early Lung Cancer Investigators |
Eur. J. Cancer Prev. |
2014 |
NLST |
| Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. |
25065710
|
Gareen IF, Duan F, Greco EM, Snyder BS, Boiselle PM, Park ER, Fryback D, Gatsonis C |
Cancer |
2014 |
NLST |
| Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. |
25044253
|
Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y |
Urol. Oncol. |
2014 |
NLST, PLCO |
| Comparing benefits from many possible computed tomography lung cancer screening programs: extrapolating from the National Lung Screening Trial using comparative modeling. |
24979231
|
McMahon PM, Meza R, Plevritis SK, Black WC, Tammemagi CM, Erdogan A, ten Haaf K, Hazelton W, Holford TR, Jeon J, Clarke L, Kong CY, Choi SE, Munshi VN, Han SS, van Rosmalen J, Pinsky PF, Moolgavkar S, de Koning HJ, Feuer EJ |
PLoS ONE |
2014 |
NLST |
